• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION VALVE CONTEGRA; CONDUIT,VALVED,PULMONIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION VALVE CONTEGRA; CONDUIT,VALVED,PULMONIC Back to Search Results
Model Number CONTEGRA
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Information (3190)
Event Date 01/01/2014
Event Type  Injury  
Manufacturer Narrative
Citation: sachweh js et al.Size matters: longevity of valved rvot conduits is mainly related to the conduit diameter.Thorac cardiovasc surg 2014; 62 - op56.Doi: 10.1055/s-0034-1367133.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information, it could not be determined whether these observations have been previously reported.Without the return of the product, no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding the longevity of valved conduits used in right ventricular outflow tract reconstruction.All data were collected between 1997 and 2013.The study population included 119 patients (mean age 9 years; mean weight 29 kg), 50 of which were implanted with a medtronic contegra valved conduit and 36 were implanted with a medtronic hancock valved conduit.No serial numbers were provided.The surgical mortality rate was 1.7% and late mortality rate 2.6% (reported to be not related to conduit failure).Multiple manufacturers were noted in the literature; based on the limited available information, medtronic product did not cause or contribute to these deaths.Among all patients, adverse events included: reoperation and/or intervention (defined as conduit dilatation or valve replacement).Multiple manufacturers were noted in the literature; however, based on the available information, medtronic product may have caused or contributed to these adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALVE CONTEGRA
Type of Device
CONDUIT,VALVED,PULMONIC
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8318325
MDR Text Key135493103
Report Number2025587-2019-00530
Device Sequence Number1
Product Code MWH
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
H020003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 02/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/07/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCONTEGRA
Device Catalogue NumberCONTEGRA
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/19/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age9 YR
Patient Weight29
-
-